Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Vaccine Production01:23

Vaccine Production

113
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
113
Vaccinations01:51

Vaccinations

43.7K
Overview
43.7K
Vaccines01:21

Vaccines

64
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
64

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating CD38<sup>+</sup> regulatory T cells are decreased in bone fracture non-union with chronic subclinical infection.

Scientific reports·2026
Same author

Respiratory Viral Infections and the Tonsillar Transcriptome: An Exploratory Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Effects of Common Food Additives Kappa-, Iota- and Lambda-Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

The Rising Tide of Allergic Rhinitis in China: Driving Innovation Forward.

Allergy·2026
Same author

Risk and Protective Factors for Infection, Severe Disease, and Mortality in Epidemic Respiratory Viruses.

Allergy·2026
Same author

Polyethylene Terephthalate Micro and Nanoplastics Induce Oxidative and Endoplasmic Reticulum Stress, Compromising Intestinal Epithelial Integrity and Viability.

Allergy·2026

Related Experiment Video

Updated: Apr 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.1K

Novel immunotherapy vaccine development.

Marek Jutel1, Cezmi A Akdis

  • 1aDepartment of Clinical Immunology, Wrocław Medical University bALL-MED Medical Research Institute, Wrocław, Poland cSwiss Institute of Allergy and Asthma Research, Davos, Switzerland.

Current Opinion in Allergy and Clinical Immunology
|October 12, 2014
PubMed
Summary
This summary is machine-generated.

New allergen immunotherapy (AIT) strategies aim to improve treatment efficacy and safety. Advances in genetic engineering and vaccine development offer potential for a complete cure for allergic diseases.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

2.2K

Related Experiment Videos

Last Updated: Apr 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.1K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

2.2K

Area of Science:

  • Immunology
  • Allergy Research
  • Vaccine Development

Background:

  • Allergen-specific immunotherapy (AIT) is the only curative treatment for allergic diseases.
  • Current AIT methods face challenges including limited efficacy, side effects, poor patient adherence, and high costs due to long treatment durations (3-5 years).

Purpose of the Study:

  • To review current approaches for optimizing allergen immunotherapy (AIT).
  • To explore conceptual studies in experimental models and clinical studies for AIT improvement.

Main Methods:

  • Review of experimental and clinical studies on AIT optimization.
  • Analysis of novel vaccine development strategies and administration routes.

Main Results:

  • Promising approaches include using hypoallergenic recombinant allergen derivatives and immunogenic peptides to bypass IgE binding and target T cells.
  • New adjuvants, innate immune response stimulators, fusion of allergens with immune modifiers, and alternative administration routes enhance AIT efficacy and safety.
  • Genetic engineering allows production of well-defined allergen vaccines with modified molecular structures.

Conclusions:

  • Advances in allergen vaccine production and immunization protocols are key to achieving the ultimate goal of AIT.
  • These innovations bring closer the possibility of a complete cure for a significant number of allergic patients.